Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 796 for cardiovascular

Edit search filters
  1. Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.

    Rochester, MN

  2. A Study to Evaluate Cardiac Output and Recovery Time

    Jacksonville, FL

  3. Studies using Doubly Labeled Water in Measuring Total Energy Expenditure

    Rochester, MN

  4. Effects of Chardonnay Seed Flour on Vascular Health

    Rochester, MN

  5. The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease

    Rochester, MN

  6. Assessment of Coronary Plaque Composition

    Rochester, MN

  7. The eMESH 1 Feasibility Study

    Rochester, MN

  8. Topical Tranexamic Acid in Complex Cardiac Surgery: Does it Reduce Transfusion Need?

    Rochester, MN

  9. A Dose Titration Study to Assess the Effects of SAR407899 in Patients With Microvascular Angina and/or Persistent Stable Angina Despite Angiographically Successful Elective PCI

    Rochester, MN

  10. Resistance Training in HFpEF

    Rochester, MN

.

Mayo Clinic Footer